亚太放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型（外束放射治疗和内束放射治疗）和应用（乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等）

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)

No. of Pages: 89    |    Report Code: BMIRE00030984    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Radiation Oncology Market
Free Sample Buy Now
2023 年亚太放射肿瘤学市场价值为 11.0574 亿美元，预计到 2031 年将达到 34.1789 亿美元；预计 2023 年至 2031 年的复合年增长率为 15.1%。

放射肿瘤学战略举措推动亚太放射肿瘤学市场发展

放射肿瘤学在癌症治疗中具有巨大潜力。此外，市场参与者在产品开发、创新、产品发布、产品批准、合并、收购和合作等方面不断发展放射治疗，预计将促进市场增长。市场上最近采取的一些战略举措包括

- 2024 年 5 月，Elekta 推出了其最新的直线加速器 (linac) Evo，这是一款具有新型高清 AI 增强成像的 CT-Linac，能够提供离线和在线自适应放射治疗以及改进的标准图像引导放射治疗。

- 2024 年 5 月，Icon Group 与 Cyberknife Australia Pty Ltd 合作建立多达 6 家新的放射肿瘤诊所（拟议的合资企业），这些诊所将使用“Cyberknife”系统提供放射肿瘤治疗。

- 2024 年 5 月，GE HealthCare 推出了 Revolution RT，这是一款新的放射治疗计算机断层扫描 (CT) 解决方案，具有创新的硬件和软件解决方案，有助于提高成像准确性，同时简化模拟工作流程，为临床医生和患者提供更加个性化和无缝的肿瘤护理途径体验。

- 2024 年 4 月，Accuray Incorporated 在 ESTRO 2024 上展示了旨在改善癌症治疗体验的硬件和软件方面的进步。最新一代 CyberKnife 和 Radixact 平台为医疗护理团队提供了必要的技术，以扩大放射治疗的治愈能力并实现今年大会的重点，即弥合护理差距。

- 2023 年 9 月，MVision AI 推出了第一个全面的基于指南的分割 (GBS) 解决方案，用于有效的放射治疗轮廓勾画。Guide 有助于临床团队准确评估 AI 生成的结构，从而使他们能够提高勾画技能。Verify 允许对轮廓进行视觉和体积比较，方便诊所观察相似点和差异点。Guide Verify 和 Contour+ 的联合实施涵盖了放射治疗轮廓勾画的所有临床需求。

因此，放射肿瘤学市场的市场参与者纷纷推出战略举措，预计将扩大市场增长并为放射肿瘤学市场创造充足的机会。

亚太放射肿瘤学市场概览

由于技术的重大进步，中国放射肿瘤学领域发展迅速。合资企业在提高放射肿瘤学系统的可及性方面发挥了至关重要的作用。通过这些举措，公司还专注于开发高科技治疗产品。中国同位素辐照有限公司（CIRC）与美国放射治疗系统开发商Accuray于2019年1月成立合资企业。该项目利用Accuray的尖端治疗解决方案和本地制造能力来满足中国市场尚未满足的需求。这些举措表明中国致力于在国内发展放射肿瘤学技能，这将为未来几年的放射肿瘤学市场带来值得关注的前景。

亚太地区放射肿瘤学市场收入及预测至 2031 年（百万美元）

亚太地区放射肿瘤学市场细分

亚太地区放射肿瘤学市场分为类型、应用和国家。

根据类型，亚太地区放射肿瘤学市场分为外束放射治疗和内束放射治疗。外束放射治疗部分在 2023 年占据了更大的市场份额。

在应用方面，亚太地区放射肿瘤学市场分为乳腺癌、前列腺癌、肺癌、头颈癌、宫颈癌等。乳腺癌部分在 2023 年占据了最大的市场份额。

按国家/地区划分，亚太地区放射肿瘤学市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2023 年，中国占据了亚太地区放射肿瘤学市场的主导份额。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Panacea Medical Technologies Pvt. Ltd 和 Curium 是亚太地区放射肿瘤学市场的一些领先公司。

Asia Pacific Radiation Oncology Strategic Insights

Strategic insights for Asia Pacific Radiation Oncology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-radiation-oncology-market-strategic-framework.webp
Get more information on this report

Asia Pacific Radiation Oncology Report Scope

Report Attribute Details
Market size in 2023 US$ 1,105.74 Million
Market Size by 2031 US$ 3,417.89 Million
Global CAGR (2023 - 2031) 15.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 类型
  • 外照射放射治疗
  • 内照射放射治疗
By 应用
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 头颈癌
  • 宫颈癌
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Panacea Medical Technologies Pvt. Ltd
  • Curium.
    		•
    Get more information on this report

    Asia Pacific Radiation Oncology Regional Insights

    The regional scope of Asia Pacific Radiation Oncology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-radiation-oncology-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Asia Pacific Radiation Oncology Market

    1. Varian Medical Systems Inc.
    2. Elekta AB.
    3. Accuray Incorporated.
    4. IBA Worldwide (Ion Beam Applications SA).
    5. Becton Dickinson and Co.
    6. Mevion Medical Systems.
    7. NTP RADIOISOTOPES.
    8. Mallinckrodt Plc.
    9. Panacea Medical Technologies Pvt. Ltd
    10. Curium.
    Frequently Asked Questions
    How big is the Asia Pacific Radiation Oncology Market?

    The Asia Pacific Radiation Oncology Market is valued at US$ 1,105.74 Million in 2023, it is projected to reach US$ 3,417.89 Million by 2031.

    What is the CAGR for Asia Pacific Radiation Oncology Market by (2023 - 2031)?

    As per our report Asia Pacific Radiation Oncology Market, the market size is valued at US$ 1,105.74 Million in 2023, projecting it to reach US$ 3,417.89 Million by 2031. This translates to a CAGR of approximately 15.1% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Radiation Oncology Market report typically cover these key segments-

  • 类型 (外照射放射治疗, 内照射放射治疗)
  • 应用 (乳腺癌, 前列腺癌, 肺癌, 头颈癌, 宫颈癌)

    • What is the historic period, base year, and forecast period taken for Asia Pacific Radiation Oncology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Radiation Oncology Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Asia Pacific Radiation Oncology Market?

    The Asia Pacific Radiation Oncology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Panacea Medical Technologies Pvt. Ltd
  • Curium.
    • Who should buy this report?

    The Asia Pacific Radiation Oncology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Radiation Oncology Market value chain can benefit from the information contained in a comprehensive market report.

    asia-pacific-radiation-oncology-market